Agios Pharmaceuticals



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Arrowhead Research USD -156177000 1M 2024-12
Astellas Pharma JPY -63042000000 156.59B 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Daiichi Sankyo JPY 78.78B 31.82B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Exelixis USD 171.1M 24.2M 2025-01
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
Incyte USD 320.2M 128.19M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Merck USD 7.12B 1.06B 2024-12
Moderna USD -993000000 1.19B 2024-12
Novartis USD 5.19B 319M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Agios Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.